Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus (original) (raw)

Nature volume 508, pages 541–545 (2014)Cite this article

Subjects

Abstract

Akt, also known as protein kinase B, plays key roles in cell proliferation, survival and metabolism. Akt hyperactivation contributes to many pathophysiological conditions, including human cancers1,2,3, and is closely associated with poor prognosis and chemo- or radiotherapeutic resistance4. Phosphorylation of Akt at S473 (ref. 5) and T308 (ref. 6) activates Akt. However, it remains unclear whether further mechanisms account for full Akt activation, and whether Akt hyperactivation is linked to misregulated cell cycle progression, another cancer hallmark7. Here we report that Akt activity fluctuates across the cell cycle, mirroring cyclin A expression. Mechanistically, phosphorylation of S477 and T479 at the Akt extreme carboxy terminus by cyclin-dependent kinase 2 (Cdk2)/cyclin A or mTORC2, under distinct physiological conditions, promotes Akt activation through facilitating, or functionally compensating for, S473 phosphorylation. Furthermore, deletion of the cyclin A2 allele in the mouse olfactory bulb leads to reduced S477/T479 phosphorylation and elevated cellular apoptosis. Notably, cyclin A2-deletion-induced cellular apoptosis in mouse embryonic stem cells is partly rescued by S477D/T479E-Akt1, supporting a physiological role for cyclin A2 in governing Akt activation. Together, the results of our study show Akt S477/T479 phosphorylation to be an essential layer of the Akt activation mechanism to regulate its physiological functions, thereby providing a new mechanistic link between aberrant cell cycle progression and Akt hyperactivation in cancer.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Zoncu, R., Efeyan, A. & Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Rev. Mol. Cell Biol. 12, 21–35 (2010)
    Article Google Scholar
  2. Manning, B. D. & Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129, 1261–1274 (2007)
    Article CAS Google Scholar
  3. Toker, A. Akt signaling: a damaging interaction makes good. Trends Biochem. Sci. 33, 356–359 (2008)
    Article CAS Google Scholar
  4. Luo, J., Manning, B. D. & Cantley, L. C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257–262 (2003)
    Article CAS Google Scholar
  5. Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098–1101 (2005)
    Article ADS CAS Google Scholar
  6. Stephens, L. et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710–714 (1998)
    Article ADS CAS Google Scholar
  7. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)
    Article CAS Google Scholar
  8. Gao, X. & Zhang, J. Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains. Mol. Biol. Cell 19, 4366–4373 (2008)
    Article CAS Google Scholar
  9. Sakaue-Sawano, A. et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132, 487–498 (2008)
    Article CAS Google Scholar
  10. McGarry, T. J. & Kirschner, M. W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93, 1043–1053 (1998)
    Article CAS Google Scholar
  11. Murphy, M. et al. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nature Genet. 15, 83–86 (1997)
    Article CAS Google Scholar
  12. Maddika, S. et al. Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. J. Cell Sci. 121, 979–988 (2008)
    Article CAS Google Scholar
  13. Adams, P. D. et al. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16, 6623–6633 (1996)
    Article CAS Google Scholar
  14. Kalaszczynska, I. et al. Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 138, 352–365 (2009)
    Article CAS Google Scholar
  15. Geley, S. et al. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 153, 137–148 (2001)
    Article CAS Google Scholar
  16. Malumbres, M. & Barbacid, M. Mammalian cyclin-dependent kinases. Trends Biochem. Sci. 30, 630–641 (2005)
    Article CAS Google Scholar
  17. Gray, C. H. & Barford, D. Getting in the ring: proline-directed substrate specificity in the cell cycle proteins Cdc14 and CDK2-cyclinA3. Cell Cycle 2, 500–502 (2003)
    Article CAS Google Scholar
  18. Liu, P., Kenney, J. M., Stiller, J. W. & Greenleaf, A. L. Genetic organization, length conservation, and evolution of RNA polymerase II carboxyl-terminal domain. Mol. Biol. Evol. 27, 2628–2641 (2010)
    Article CAS Google Scholar
  19. Stokes, M. P. et al. PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS. Mol. Cell. Proteom. 11, 187–201 (2012)
    Article CAS Google Scholar
  20. Bozulic, L., Surucu, B., Hynx, D. & Hemmings, B. A. PKBα/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol. Cell 30, 203–213 (2008)
    Article CAS Google Scholar
  21. Xie, X. et al. IκB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc. Natl Acad. Sci. USA 108, 6474–6479 (2011)
    Article ADS CAS Google Scholar
  22. Yang, J. et al. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nature Struct. Biol. 9, 940–944 (2002)
    Article CAS Google Scholar
  23. Yang, J. et al. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell 9, 1227–1240 (2002)
    Article CAS Google Scholar
  24. Alessi, D. R., Pearce, L. R. & Garcia-Martinez, J. M. New insights into mTOR signaling: mTORC2 and beyond. Sci. Signal. 2, pe27 (2009)
    Article Google Scholar
  25. Maira, S. M. et al. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science 294, 374–380 (2001)
    Article ADS CAS Google Scholar
  26. Gao, T., Furnari, F. & Newton, A. C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18, 13–24 (2005)
    Article CAS Google Scholar
  27. Gaveriaux-Ruff, C. & Kieffer, B. L. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases. Pharmacol. Ther. 113, 619–634 (2007)
    Article CAS Google Scholar
  28. Burgess, D. J. Senescence: double or quit? Nature Rev. Cancer 11, 389 (2011)
    Article CAS Google Scholar
  29. Butt, A. J. et al. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv. Exp. Med. Biol. 630, 189–205 (2008)
    Article CAS Google Scholar
  30. Altomare, D. A. & Testa, J. R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 24, 7455–7464 (2005)
    Article CAS Google Scholar
  31. Gao, D. et al. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nature Cell Biol. 11, 397–408 (2009)
    Article CAS Google Scholar
  32. Gao, D. et al. Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways. Mol. Biol. Cell 20, 3305–3316 (2009)
    Article CAS Google Scholar
  33. Wei, W. et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194–198 (2004)
    Article ADS CAS Google Scholar
  34. Peng, X. D. et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17, 1352–1365 (2003)
    Article CAS Google Scholar
  35. Silva, J. M. et al. Second-generation shRNA libraries covering the mouse and human genomes. Nature Genet. 37, 1281–1288 (2005)
    Article CAS Google Scholar
  36. Tsou, P., Zheng, B., Hsu, C. H., Sasaki, A. T. & Cantley, L. C. A fluorescent reporter of AMPK activity and cellular energy stress. Cell Metab. 13, 476–486 (2011)
    Article CAS Google Scholar
  37. Karanam, K., Kafri, R., Loewer, A. & Lahav, G. Quantitative live cell imaging reveals a gradual shift between DNA repair mechanisms and a maximal use of HR in mid S phase. Mol. Cell 47, 320–329 (2012)
    Article CAS Google Scholar
  38. Dean, P. N. & Jett, J. H. Mathematical analysis of DNA distributions derived from flow microfluorometry. J. Cell Biol. 60, 523–527 (1974)
    Article CAS Google Scholar
  39. Toettcher, J. E. et al. Distinct mechanisms act in concert to mediate cell cycle arrest. Proc. Natl Acad. Sci. USA 106, 785–790 (2009)
    Article ADS CAS Google Scholar
  40. Gao, D. et al. Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. Mol. Cell 39, 797–808 (2010)
    Article CAS Google Scholar
  41. Inuzuka, H. et al. Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(β-TRCP) ubiquitin ligase. Cancer Cell 18, 147–159 (2010)
    Article CAS Google Scholar
  42. Wei, W., Jobling, W. A., Chen, W., Hahn, W. C. & Sedivy, J. M. Abolition of cyclin-dependent kinase inhibitor p16Ink4a and p21Cip1/Waf1 functions permits Ras-induced anchorage-independent growth in telomerase-immortalized human fibroblasts. Mol. Cell. Biol. 23, 2859–2870 (2003)
    Article CAS Google Scholar
  43. Inuzuka, H. et al. Acetylation-dependent regulation of Skp2 function. Cell 150, 179–193 (2012)
    Article CAS Google Scholar
  44. Min, S. H. et al. Negative regulation of the stability and tumor suppressor function of fbw7 by the pin1 prolyl isomerase. Mol. Cell 46, 771–783 (2012)
    Article CAS Google Scholar
  45. Otero, J. J. et al. Cerebellar cortical lamination and foliation require cyclin A2. Dev. Biol. 385, 328–339 (2014)
    Article CAS Google Scholar

Download references

Acknowledgements

We thank J. Guo, J.J. Liu, A.W. Lau, S. Shaik, A. Tron, X. Dai and K. Xu for reading the manuscript, S.B. Breitkopf for help with mass spectrometry experiments, Y. Geng, L. Liu, K. Ran, R. Chin and S. Elloul for providing reagents, and members of the Wei, Toker, Sicinski, Pandolfi and Cantley laboratories for discussions. W.W. is an American Cancer Society and a Leukemia & Lymphoma Society research scholar. P.L. is supported by 5T32HL007893. This work was supported in part by National Institutes of Health grants to W.W. (GM089763, GM094777 and CA177910), J.M.A. (2P01CA120964) and P.S. (R01CA132740).

Author information

Author notes

  1. Zhiwei Wang & Lewis Cantley
    Present address: Present addresses: The Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou 215123, China (Z.W.); Cancer Center at Weill Cornell Medical College and NewYork-Presbyterian Hospital, New York, New York 10065, USA (L.C.).,

Authors and Affiliations

  1. Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02215, Massachusetts, USA
    Pengda Liu, Hiroyuki Inuzuka, Daming Gao, Wenjian Gan, Antonella Papa, Lixin Wan, Zhiwei Wang, Alex Toker, Pier Paolo Pandolfi & Wenyi Wei
  2. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, 02215, Massachusetts, USA
    Michael Begley, Peiling Tsou, Antonella Papa, Min Yuan, Kun-Ping Lu, Pier Paolo Pandolfi, John M. Asara & Lewis Cantley
  3. Department of Systems Biology, Harvard Medical School, Boston, 02115, Massachusetts, USA
    Michael Begley, Peiling Tsou, Marc W. Kirschner & Lewis Cantley
  4. Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Genetics, Harvard Medical School, Boston, 02115, Massachusetts, USA
    Wojciech Michowski & Piotr Sicinski
  5. Department of Cell Biology, Harvard Medical School, Boston, 02115, Massachusetts, USA
    Miriam Ginzberg, Bo Zhai & Steven P. Gygi
  6. Cancer Genetics Program and Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, 02115, Massachusetts, USA
    Antonella Papa & Pier Paolo Pandolfi
  7. Cell Signaling Technology, Danvers, 01923, Massachusetts, USA
    Amrik Singh
  8. Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, 02215, Massachusetts, USA
    Byeong Mo Kim & Tae Ho Lee

Authors

  1. Pengda Liu
    You can also search for this author inPubMed Google Scholar
  2. Michael Begley
    You can also search for this author inPubMed Google Scholar
  3. Wojciech Michowski
    You can also search for this author inPubMed Google Scholar
  4. Hiroyuki Inuzuka
    You can also search for this author inPubMed Google Scholar
  5. Miriam Ginzberg
    You can also search for this author inPubMed Google Scholar
  6. Daming Gao
    You can also search for this author inPubMed Google Scholar
  7. Peiling Tsou
    You can also search for this author inPubMed Google Scholar
  8. Wenjian Gan
    You can also search for this author inPubMed Google Scholar
  9. Antonella Papa
    You can also search for this author inPubMed Google Scholar
  10. Byeong Mo Kim
    You can also search for this author inPubMed Google Scholar
  11. Lixin Wan
    You can also search for this author inPubMed Google Scholar
  12. Amrik Singh
    You can also search for this author inPubMed Google Scholar
  13. Bo Zhai
    You can also search for this author inPubMed Google Scholar
  14. Min Yuan
    You can also search for this author inPubMed Google Scholar
  15. Zhiwei Wang
    You can also search for this author inPubMed Google Scholar
  16. Steven P. Gygi
    You can also search for this author inPubMed Google Scholar
  17. Tae Ho Lee
    You can also search for this author inPubMed Google Scholar
  18. Kun-Ping Lu
    You can also search for this author inPubMed Google Scholar
  19. Alex Toker
    You can also search for this author inPubMed Google Scholar
  20. Pier Paolo Pandolfi
    You can also search for this author inPubMed Google Scholar
  21. John M. Asara
    You can also search for this author inPubMed Google Scholar
  22. Marc W. Kirschner
    You can also search for this author inPubMed Google Scholar
  23. Piotr Sicinski
    You can also search for this author inPubMed Google Scholar
  24. Lewis Cantley
    You can also search for this author inPubMed Google Scholar
  25. Wenyi Wei
    You can also search for this author inPubMed Google Scholar

Contributions

P.L., M.B., W.M., H.I., A.P., M.G., D.G., P.T. and W.G. performed most of the experiments with assistance from B.K., L.W., A.S., B.Z. and M.Y. W.W., P.S., P.P.P., L.C. and P.L. designed the experiments. W.W., L.C., P.S., P.P.P., M.W.K. and A.T. supervised the study. P.L. and W.W. wrote the manuscript. All authors commented on the manuscript.

Corresponding author

Correspondence toWenyi Wei.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

PowerPoint slides

Rights and permissions

About this article

Cite this article

Liu, P., Begley, M., Michowski, W. et al. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.Nature 508, 541–545 (2014). https://doi.org/10.1038/nature13079

Download citation

Editorial Summary

Phosphorylation-mediated activation of Akt

The serine/threonine protein kinase Akt is an important cellular signalling molecule that functions in a broad range of processes, such as cell proliferation, survival and metabolism. Its activation is known to be controlled by two key phosphorylation sites — one in the catalytic domain and the other in a hydrophobic motif. Here, Wenyi Wei and colleagues show that Akt activity fluctuates across the cell cycle, and phosphorylation by Cdk2/cyclin A or mTORC2 at two sites near the carboxy terminus of the molecule promotes its full activation under distinct physiological conditions. These novel phosphorylation events also seem important in pathological activities of Akt, which include cancer, diabetes and neurological diseases.